Baseline feature of a randomized trial assessing the effects of disease management programs for the prevention of recurrent ischemic stroke
Yasuko Fukuoka,Naohisa Hosomi,Takeshi Hyakuta,Toyonori Omori,Yasuhiro Ito,Jyunichi Uemura,Kazumi Kimura,Masayasu Matsumoto,Michiko Moriyama,DMP Stroke Trial Investigators,Yasuhiro Itou,Toshiho Ohtsuki,Junichi Uemura,Takeshi Yasuda,Masako Hayashi,Hiromi Kaku,Madoka Kawai,Eri Kawanishi,Yukiko Kobayashi,Kazuyuki Nagatsuka,Toshiharu Ohira,Mami Sakamoto,Akira Sumigaichi,Harumi Yamashiro,Kazue Amano,Hitomi Hiramatsu,Keiko Ishida,Natsuko Masamori,Natsuko Okazaki,Shuichi Oki,Setsuko Shimada,Rie Goto,Kaoruko Masuoka,Kurumi Muranaka,Shinobu Hamasaki,Yorie Iwai,Masayuki Sumida,Shinichiro Takeshita,Eiji Imamura,Tomoyuki Kono,Kenji Matsuda,Eiichi Nomura,Tomohiko Ooshita,Youko Ota,Naoko Ochiai,Kayoko Tomita,Midori Azeuchi,Hidemi Daikoku,Rika Ikeda,Hisayo Izumiyama,Hatsuyo Kataoka,Shingo Kishita,Reiko Maeda,Asako Matsuura,Yoshiko Miyazako,Mika Mukai,Yoko Nishikawa,Kiyomi Saito,Izumi Sugie,Mutsumi Sugihara,Akiko Suyama,Tomoko Uesaka,Emiko Yamahiro,Hirotaka Agetsuma,Takaaki Akagawa,Shigeru Aoyama,Osamu Araki,Katsuya Emoto,Katsuhiko Nomura,Itaru Tani,Kenichi Watanabe,Hiroyuki Yamasaki,Tomohiro Natsume,Toshirou Asai,Shinji Chikuie,Shigeru Hirata,Michihiro Domyo,Kouichirou Morita,Genshi Egusa,Katsuaki Ensako,Yutaka Fujita,Mikio Fujita,Machiko Fukai,Kohei Fukuhara,Akihiko Fukushima,Hiroshi Ishibashi,Kentaro Ota,Kazuto Takamura,Katsuhisa Takaoka,Naoki Funahashi,Yasuhiro Futagami,Kentaro Kuwahara,Tatsuhiro Fujimura,Kiyoshi Harada,Yoshiko Nishizawa,Yumi Hasegawa,Kenya Hasegawa,Hisakatsu Hashimoto,Hidenobu Hayashi,Toshiyuki Yamaguchi,Teisuke Hirabuki,Kentaro Hiraiwa,Shuzo Hirakawa,Takafumi Kondou,Masayuki Hiromoto,Kazuoki Dai,Kenji Nishioka,Susumu Yamada,Yoshimasa Sueda,Mikio Fujimoto,Shinya Takahashi,Hisato Ideshita,Masaaki Ikedo,Takaho Ikuta,Masaki Inagaki,Hiroyasu Inoue,Fukashi Ishibashi,Makoto Ishida,Hirofumi Ishihara,Makoto Ishikawa,Junko Ito,Ken Itsuki,Yukiyoshi Iwasaki,Yumi Yamasaki,Sayuri Okushin,Shigeru Katamura,Shinkuro Kataoka,Hiroshi Kato,Kato Iin,Akiko Kato,Eishi Kato,Hirotaka Katsutani,Tsuyoshi Kawakami,Hideaki Kimura,Masuji Kinoshita,Satoshi Hadatsuki,Yoshiharu Kiyota,Hiroko Kobayakawa,Naofumi Kodama,Haruyasu Kondo,Kaoru Terasaka,Hiroko Seto,Tadakazu Matsuda,Shigeru Matsuzaka,Ryo Ogami,Kunihiro Namba,Takashi Mikami,Soichiro Yamamoto,Hitoshi Tanaka,Yasunori Mizuno,Hiroshi Mutou,Toshimasa Nagai,Koji Nagao,Ken Nagatani,Hidetoshi Naito,Takashi Nakagawa,Eiji Nakamura,Naokazu Tsurumi,Yasunori Neishi,Hitohisa Niimi,So Tsuboi,Hiroyuki Ochiai,Kenichi Ochiai,Naoya Shigeoka,Masayuki Ogihara,Takamasa Ohta,Atsuo Ohya,Tsuyoshi Fujita,Taro Okamoto,Hirosuke Yamaji,Ritsuko Asakura,Hideaki Okita,Kazunori Okubo,Takashi Omoto,Norihisa Oohira,Hidefumi Kobayashi,Yuichi Oshita,Keiko Hiramoto,Atsushi Ozawa,Toshifumi Saito,Tomoko Hasegawa,Koji Kato,Eiji Sanada,Tsuyoshi Sugiyama,Haruki Takahashi,Takashi Mizuno,Toru Kawase,Masatoshi Otake,Hideyo Amioka,Yoshifumi Shirotani,Hirosuke Fujisawa,Masashi Suganuma,Osamu Sugiura,Fumihiko Sugiyama,Kiyoshi Sugiyama,Ryu Kawamura,Mutsuo Suzukawa,Keiji Tachi,Sadamatsu Takayama,Susumu Tomita,Takeshi Tanimukai,Kunihiko Nakamura,Hideo Tomino,Masahiro Toyota,Kazunori Imai,Chitose Mae,Miyuki Naruse,Suguru Nishida,Rei Ogura,Jyunichiro Suzuki,Mami Yoshimura,Hiroshi Sakamoto,Motoki Tsubota,Yuji Muraoka,Mamoru Toyofuku,Katsuzo Tsuji,Goji Ushio,Shigeru Sasaki,Makoto Watanabe,Wataru Yakushiji,Masaharu Yamamoto,Seigo Deguchi,Tomoya Mukai,Hideki Yamashina,Yoshifumi Yamashita,Akihiro Yoshida,Yu Sakashita,Masaaki Zenke
DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.10.007
Abstract:Background: Comprehensive and long-term patient education programs designed to improve self-management can help patients better manage their medical condition. Using disease management programs (DMPs) that were created for each of the risk factor according to clinical practice guidelines, we evaluate their influence on the prevention of stroke recurrence. Methods: This is a randomized study conducted with ischemic stroke patients within 1 year from their onset. Subjects in the intervention group received a 6-month DMPs that included self-management education provided by a nurse along with support in collaboration with the primary care physician. Those in the usual care group received ordinary outpatient care. The primary end point is a difference of the Framingham risk score-general cardiovascular disease 10-year risk [corrected]. Patients were enrolled for 2 years with plans for a 2-year follow-up after the 6-month education period (total of 30 months). Results: A total of 321 eligible subjects (average age, 67.3 years; females, 96 [29.9%]), including 21 subjects (6.5%) with transient ischemic attack, were enrolled in this study. Regarding risk factors for stroke, 260 subjects (81.0%) had hypertension, 249 subjects (77.6%) had dyslipidemia, 102 subjects (31.8%) had diabetes mellitus, 47 subjects (14.6%) had atrial fibrillation, and 98 subjects (30.5%) had chronic kidney disease. There were no significant differences between the 2 groups with respect to subject characteristics. Conclusions: This article describes the rationale, design, and baseline features of a randomized controlled trial that aimed to assess the effects of DMPs for the secondary prevention of stroke. Subject follow-up is in progress and will end in 2015.